Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma

Affiliations

• ¹ APHP, Pharmacology-Genetic Laboratory, Saint Louis Hospital, INSERM U976, 75010, Paris, France.
• ² APHP, Hotel Dieu Hospital, Centre for Clinical Epidemiology, University Paris Diderot, 75010, Paris, France.
• ³ APHP, Department of Pathology, Saint Louis Hospital, INSERM U1165, 75010, Paris, France.
• ⁴ APHP, Department of Dermatology, Saint Louis Hospital, 75010, Paris, France.
• ⁵ Department of Dermatology, Montpellier University Hospital, INSERM U1058, Montpellier, 34295, France.
• ⁶ Skin Cancer Unit, Dermatology Department, Bordeaux University Hospital, Bordeaux, 33000, France.
• ⁷ APHP, Virology Unit, Microbiology Department, Saint Louis Hospital, 75010, Paris, France.
• ⁸ APHP, CITOH, Saint Louis Hospital, 75010, Paris, France.
• ⁹ APHP Toxicology Laboratory, Hospital Kremlin Bicêtre, Le Kremlin, 94275, Bicêtre, France.
• ¹⁰ APHP, Immunology and Histocompatibility Laboratory, Saint Louis Hospital, University Paris Diderot, INSERM UMR1160, 75010, Paris, France.
• ¹¹ Dermatology Department, Cochin Hospital, Paris Sorbonne University, INSERM U101675014, Paris, France.
• ¹² University Paris Diderot, INSERM U976, 75010, Paris, France.